Plasma Metabolomics of Community Acquired Pneumonia (CAP) For Prognosis of Patients at Highest Risk of Mortality
atmire.migration.oldid | 3375 | |
dc.contributor.advisor | Winston, Brent | |
dc.contributor.author | Banoei, Mohammad Mehdi | |
dc.date.accessioned | 2015-07-13T17:22:57Z | |
dc.date.embargolift | 2017-01-08T17:22:57Z | |
dc.date.issued | 2015-07-13 | |
dc.date.submitted | 2015 | en |
dc.description.abstract | Community acquired pneumonia (CAP) is an acute disease with clinical features of lower respiratory tract infections. Early and accurate prognoses, and effective treatment, where possible, in the management of CAP are essential to decrease mortality. Metabolomic analysis is defined as the comprehensive study of low molecular-weight metabolites present in biological samples that enable the qualitative and/or quantitative measurement and analysis of multiple metabolites We showed the feasibility of metabolomics using nuclear magnetic resonance (NMR) spectroscopy, gas chromatography mass spectrometry (GC-MS) and direct infusion tandem mass spectrometry (DIMS/MS) as most common analytical platforms in association with multivariate statistical analysis to separate non-survivors and survivor of bacteria CAP and H1N1 pneumonia patients for prognosis of mortality. In conclusion, this study may not only be instrumental in predicting the mortality of CAP patients within 24 hours of hospitalization, but may also allow for the rapid identification of the infective organism in CAP. | en_US |
dc.description.embargoterms | 18 months | en_US |
dc.identifier.citation | Banoei, M. M. (2015). Plasma Metabolomics of Community Acquired Pneumonia (CAP) For Prognosis of Patients at Highest Risk of Mortality (Master's thesis, University of Calgary, Calgary, Canada). Retrieved from https://prism.ucalgary.ca. doi:10.11575/PRISM/27367 | en_US |
dc.identifier.doi | http://dx.doi.org/10.11575/PRISM/27367 | |
dc.identifier.uri | http://hdl.handle.net/11023/2354 | |
dc.language.iso | eng | |
dc.publisher.faculty | Graduate Studies | |
dc.publisher.institution | University of Calgary | en |
dc.publisher.place | Calgary | en |
dc.rights | University of Calgary graduate students retain copyright ownership and moral rights for their thesis. You may use this material in any way that is permitted by the Copyright Act or through licensing that has been assigned to the document. For uses that are not allowable under copyright legislation or licensing, you are required to seek permission. | |
dc.subject | Biology--Molecular | |
dc.subject | Health Care Management | |
dc.subject | Biochemistry | |
dc.subject.classification | Metabolomics | en_US |
dc.subject.classification | Pneumonia | en_US |
dc.subject.classification | H1N1 | en_US |
dc.subject.classification | CAP | en_US |
dc.subject.classification | Prognosis of Mortality | en_US |
dc.title | Plasma Metabolomics of Community Acquired Pneumonia (CAP) For Prognosis of Patients at Highest Risk of Mortality | |
dc.type | master thesis | |
thesis.degree.discipline | Medical Science | |
thesis.degree.grantor | University of Calgary | |
thesis.degree.name | Master of Science (MSc) | |
ucalgary.item.requestcopy | true |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 2.65 KB
- Format:
- Item-specific license agreed upon to submission
- Description: